Fatty acid metabolism and DGAT1 deficiency
脂肪酸代谢和 DGAT1 缺乏
基本信息
- 批准号:6891091
- 负责人:
- 金额:$ 2.89万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-05-01 至 2007-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Obesity, a major dsk factor for type II diabetes and heart disease, has reached epidemic proportions in the U.S. Obesity results from an imbalance between energy input and output, where excess calories are stored as triglycerides. Mice lacking DGAT1, an enzyme involved in triacylglycerol synthesis, have increased energy expenditure and are therefore obesity resistant. The increased energy expenditure can be attributed to increased thermogenesis and physical activity. The objectives of this study are to investigate the mechanisms by which DGAT1 deficiency alters fatty acid metabolism. I hypothesize that DGAT1 deficiency decreases fatty acid synthesis and increases fatty acid oxidation. My specific aims are:
Specific Aim 1: To determine if fatty acid synthesis is decreased in Dgatl 4- mice.
Aim 1.1: Determine if in vivofatty acid synthesis is decreased in livers of Dgatl 4- mice fed a high-fat diet by measuring the incorporation of tritiated water into fatty acids.
Aim 1.2: Determine whether decreased activation of LXR-alpha, possibly due to increased levels of unsaturated fatty acids, is responsible for the decreased expression of fatty acid synthesis genes.
Aim 1.3: Determine the contribution of decreased expression of SREBP-lc to the obesity-resistance phenotype by treating Dgatl -/- mice with an LXR-alpha agonist.
Specific Aim 2: Determine if fatty acid oxidation is increased in Dgatl _- mice.
Aim 2.1: Determine if there is increased fatty acid oxidation by measuring the formation of [1-14C] CO2 from [1-1"C] palmitate and measuring the serum levels of ketone bodies.
Aim 2.2: Determine if there is increased expression of genes implicated in fatty acid oxidation.
Aim 2.3: Determine if PPAR_, a master transcriptional regulator of fatty acid oxidation, is required for the obesity resistance phenotype of Dgat1-/-mice.
描述(由申请人提供):肥胖是II型糖尿病和心脏病的主要致病因素,在美国已达到流行病的程度。肥胖是由于能量输入和输出之间的不平衡造成的,过量的卡路里以甘油三酯的形式储存。缺乏DGAT1(一种参与三酰甘油合成的酶)的小鼠会增加能量消耗,因此具有抗肥胖能力。能量消耗的增加可归因于产热和身体活动的增加。本研究的目的是探讨DGAT1缺乏改变脂肪酸代谢的机制。我假设DGAT1缺乏会减少脂肪酸合成并增加脂肪酸氧化。我的具体目标是:
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Claudio J Villanueva其他文献
Claudio J Villanueva的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Claudio J Villanueva', 18)}}的其他基金
Role of TLE3 in the transcriptional regulation of beige adipocytes
TLE3 在米色脂肪细胞转录调控中的作用
- 批准号:
9315145 - 财政年份:2015
- 资助金额:
$ 2.89万 - 项目类别:
Role of TLE3 in the transcriptional regulation of beige adipocytes
TLE3 在米色脂肪细胞转录调控中的作用
- 批准号:
8965003 - 财政年份:2015
- 资助金额:
$ 2.89万 - 项目类别:
Transcriptional role of TLE3 in brown adipose tissue development and metabolism
TLE3在棕色脂肪组织发育和代谢中的转录作用
- 批准号:
8628832 - 财政年份:2013
- 资助金额:
$ 2.89万 - 项目类别:
Transcriptional role of TLE3 in brown adipose tissue development and metabolism
TLE3在棕色脂肪组织发育和代谢中的转录作用
- 批准号:
8425638 - 财政年份:2013
- 资助金额:
$ 2.89万 - 项目类别:
相似海外基金
Sustained eIF5A hypusination at the core of brain metabolic dysfunction in TDP-43 proteinopathies
持续的 eIF5A 抑制是 TDP-43 蛋白病脑代谢功能障碍的核心
- 批准号:
10557547 - 财政年份:2023
- 资助金额:
$ 2.89万 - 项目类别:
Mitochondrial positioning regulates redox-signaling during cell migration
线粒体定位调节细胞迁移过程中的氧化还原信号
- 批准号:
10520211 - 财政年份:2023
- 资助金额:
$ 2.89万 - 项目类别:
Ceramides as Novel Mediators of Tubular Metabolic Dysfunction Driving Kidney Injury
神经酰胺作为肾小管代谢功能障碍驱动肾损伤的新型调节剂
- 批准号:
10677394 - 财政年份:2023
- 资助金额:
$ 2.89万 - 项目类别:
Energizing and Protecting Axons Through Metabolic Coupling to Schwann Cells
通过与雪旺细胞的代谢耦合来激活和保护轴突
- 批准号:
10647707 - 财政年份:2023
- 资助金额:
$ 2.89万 - 项目类别:
Circadian and mitochondrial dysfunction in alcohol-related liver disease
酒精相关性肝病中的昼夜节律和线粒体功能障碍
- 批准号:
10667861 - 财政年份:2023
- 资助金额:
$ 2.89万 - 项目类别:
Novel first-in-class Therapeutics for Rheumatoid Arthritis
类风湿关节炎的一流新疗法
- 批准号:
10696749 - 财政年份:2023
- 资助金额:
$ 2.89万 - 项目类别:
Neuronal ABCA7 loss of function and Alzheimer’s disease
神经元 ABCA7 功能丧失与阿尔茨海默病
- 批准号:
10629715 - 财政年份:2023
- 资助金额:
$ 2.89万 - 项目类别:
Oxidative Stress and Mitochondrial Dysfunction in Chemogenetic Heart Failure
化学遗传性心力衰竭中的氧化应激和线粒体功能障碍
- 批准号:
10643012 - 财政年份:2023
- 资助金额:
$ 2.89万 - 项目类别:
Influence of Particulate Matter on Fetal Mitochondrial Programming
颗粒物对胎儿线粒体编程的影响
- 批准号:
10734403 - 财政年份:2023
- 资助金额:
$ 2.89万 - 项目类别:
High subzero preservation of liver for transplantation
移植用肝脏的高度低温保存
- 批准号:
10815970 - 财政年份:2023
- 资助金额:
$ 2.89万 - 项目类别:














{{item.name}}会员




